Stocktoria
Fresenius Medical Care AG FME.DE
DE · Deutsche Börse Xetra · XETR · stock · Healthcare · website
Fresenius Medical Care AG financials (annual, from 10-K)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $19.6B | $19.3B | $19.5B | $19.4B |
| Gross profit | $5.0B | $4.8B | $4.9B | $4.9B |
| R&D expense | $158.0M | $183.5M | $232.0M | $228.6M |
| SG&A expense | $3.0B | $3.1B | $3.2B | $3.2B |
| Operating income | $1.8B | $1.5B | $1.5B | $1.5B |
| Interest expense | $384.4M | $407.0M | $424.6M | $360.1M |
| Income tax | $321.0M | $316.1M | $300.6M | $325.0M |
| Net income | $978.4M | $537.9M | $499.0M | $673.4M |
| EPS (diluted) | $3.36 | $1.83 | $1.70 | $2.30 |
| Operating cash flow | $2.7B | $2.4B | $2.6B | $2.2B |
| Free cash flow | $1.8B | $1.7B | $1.9B | $1.4B |
| Cash & equivalents | $1.6B | $1.2B | $1.4B | $1.3B |
| Inventory | $2.1B | $2.1B | $2.2B | $2.3B |
| Total assets | $31.0B | $33.6B | $33.9B | $35.8B |
| Total liabilities | $16.7B | $17.8B | $19.1B | $20.3B |
| Shareholders' equity | $13.3B | $14.6B | $13.6B | $14.0B |
Growth · year-over-year · Revenue CAGR 0.4%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | +1.5% | -0.6% | +0.3% | — |
| Net income growth | +81.9% | +7.8% | -25.9% | — |
| EPS growth | +83.6% | +7.6% | -26.1% | — |
| Free cash flow growth | +4.7% | -13.2% | +34.7% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: company filings via Yahoo Finance · DE · as of 2025-12-31. Figures in EUR; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.